Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: Role of host genetics, antigen, and interleukin-13

Infection and Immunity

Volumn 73, Issue 1, 2005, Pages 30-38

  Noverr, Mairi C ^a   Falkowski, Nicole R ^a   McDonald, Rod A ^a   McKenzie, Andrew N ^b   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; CEFOPERAZONE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 5; OVALBUMIN;

AIRWAY; ALLERGIC ASTHMA; ANAEROBIC BACTERIUM; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; BRONCHUS HYPERREACTIVITY; CANDIDA ALBICANS; COLONY FORMING UNIT; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNGUS GROWTH; FUNGUS OVERGROWTH; HISTOLOGY; HYPERSENSITIVITY; IMMUNE RESPONSE; INBRED STRAIN; LEUKOCYTE CULTURE; LUNG; MOULD; MOUSE; NONHUMAN; PRIORITY JOURNAL; YEAST;

ANIMALS; ANTIGENS; CANDIDA ALBICANS; CEFOPERAZONE; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL TRACT; INTERLEUKIN-13; LUNG; MICE; MICE, INBRED BALB C; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY;

EID: 11144256980     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.1.30-38.2005     Document Type: Article

References (44)

1. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001, Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2:725-731.
2. Andrew, D. K., R. R. Schellenberg, J. C. Hogg, C. J. Hanna, and P. D. Pare. 1984. Physiological and immunological effects of chronic antigen exposure in immunized guinea pigs. Int. Arch. Allergy Appl. Immunol. 75:208-213.
3. Calderone, R. A. (ed.) 2001. Candida and candidiasis. ASM Press, Washington, D.C.
4. -/- mice: the role of mast cells. J. Immunol. 163:2160-2167.
5. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
6. Deurloo, D. T., B. C. van Esch, C. L. Hofstra, F. P. Nijkamp, and A. J. van Oosterhout. 2001. CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model. Am. J. Respir. Cell Mol. Biol. 25:751-760.
7. 2-microglobulin-deficient BALB/c mice. J. Exp. Med. 183:485-497.
8. Hansen, G., G. Berry, R. H. DeKruyff, and D. T. Umetsu. 1999. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Investig. 103:175-183.
9. Hilton, D. J., J. G. Zhang, D. Metcalf, W. S. Alexander, N. A. Nicola, and T. A. Willson. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497-501.
10. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol. 13:487-495.
11. Hogaboam, C. M., K. Blease, B. Mehrad, M. L. Steinhauser, T. J. Standiford, S. L. Kunkel, and N. W. Lukacs. 2000. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am. J. Pathol. 156:723-732.
12. Holt, P. G., and C. McMenamin. 1989. Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance. Clin. Exp. Allergy 19:255-262.
13. Hsieh, C. S., S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713-721.
14. Huffnagle, G. B., M. B. Boyd, N. E. Street, and M. F. Lipscomb. 1998. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160:2393-2400.
15. Karp, C. L., A. Grupe, E. Schadt, S. L. Ewart, M. Keane-Moore, P. J. Cuomo, J. Kohl, L. Wahl, D. Kuperman, S. Germer, D. Aud, G. Peltz, and M. Wills-Karp. 2000. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1:221-226.
16. Kheradmand, F., A. Kiss, J. Xu, S. H. Lee, P. E. Kolattukudy, and D. B. Corry. 2002. A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. J. Immunol. 169:5904-5911.
17. 2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice. J. Immunol. 164:2386-2395.
18. Kurup, V., H. Shen, and B. Banerjee. 2000. Respiratory fungal allergy. Microbes Infect. 2:1101-1110.
19. Kurup, V. P., S. Mauze, H. Choi, B. W. Seymour, and R. L. Coffman. 1992. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J. Immunol. 148:3783-3788.
20. Macpherson, A. J., and N. L. Harris. 2004. Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4:478-485.
21. McKenzie, A. N., J. A. Culpepper, R. de Waal Malefyt, F. Briere, J. Punnonen, G. Aversa, A. Sato, W. Dang, B. G. Cocks, S. Menon, et al. 1993. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA 90:3735-3739.
22. McKenzie, G. J., A. Bancroft, R. K. Grencis, and A. N. McKenzie. 1998. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Curr. Biol. 8:339-342.
23. McKenzie, G. J., C. L. Emson, S. E. Bell, S. Anderson, P. Fallon, G. Zurawski, R. Murray, R. Grencis, and A. N. McKenzie. 1998. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9:423-432.
24. Murali, P. S., G. Dai, A. Kumar, J. N. Fink, and V. P. Kurup. 1992. Aspergillus antigen-induced eosinophil differentiation in a murine model. Infect. Immun. 60:1952-1956.
25. Murray, C. S., A. Woodcock, and A. Custovic. 2001. The role of indoor allergen exposure in the development of sensitization and asthma. Curr. Opin. Allergy Clin. Immunol. 1:407-412.
26. Nielsen, G. D., J. S. Hansen, R. M. Lund, M. Bergqvist, S. T. Larsen, S. K. Clausen, P. Thygesen, and O. M. Poulsen. 2002. IgE-mediated asthma and rhinitis I: a role of allergen exposure? Pharmacol. Toxicol. 90:231-242.
27. Nolte, H., V. Backer, and C. Porsbjerg. 2001. Environmental factors as a cause for the increase in allergic disease. Ann. Allergy Asthma Immunol. 87:7-11.
28. Noverr, M. C., J. R. Erb-Downward, and G. B. Huffnagle. 2003. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin. Microbiol. Rev. 16:517-533.
29. Noverr, M. C., and G. B. Huffnagle. 2004. Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 12:562-568.
30. Noverr, M. C., R. M. Noggle, G. B. Toews, and G. B. Huffnagle. 2004. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect. Immun. 72:4996-5003.
31. Noverr, M. C., S. M. Phare, G. B. Toews, M. J. Coffey, and G. B. Huffnagle. 2001. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect. Immun. 69:2957-2963.
32. Noverr, M. C., D. D. Williams, G. B. Toews, and G. B. Huffnagle. 2002. Production of prostaglandins and leukotrienes by pathogenic fungi. Infect. Immun. 70:400-402.
33. a. Noverr, M. C., G. M. Cox, J. H. Perfect, and G. B. Huffnagle. 2003. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect. Immun. 71:1538-1547.
34. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
35. Russo, M., M. A. Nahori, J. Lefort, E. Gomes, A. de Castro Keller, D. Rodriguez, O. G. Ribeiro, S. Adriouch, V. Gallois, A. M. de Faria, and B. B. Vargaftig. 2001. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am. J. Respir. Cell Mol. Biol. 24:518-526.
36. Sakai, K., A. Yokoyama, N. Kohno, H. Hamada, and K. Hiwada. 2001. Prolonged antigen exposure ameliorates airway inflammation but not remodeling in a mouse model of bronchial asthma. Int. Arch. Allergy Immunol. 126:126-134.
37. + or T cell receptor (TCR)-γ/δ T cells or interferon (IFN)-γ in a murine model of allergen sensitization. J. Exp. Med. 187:721-731.
38. Tsitoura, D. C., R. L. Blumenthal, G. Berry, R. H. Dekruyff, and D. T. Umetsu. 2000. Mechanisms preventing allergen-induced airway hyperreactivity: role of tolerance and immune deviation. J. Allergy Clin. Immunol. 106:239-246.
39. Tsitoura, D. C., S. Kim, K. Dabbagh, G. Berry, D. B. Lewis, and D. T. Umetsu. 2000. Respiratory infection with influenza A virus interferes with the induction of tolerance to aeroallergens. J. Immunol. 165:3484-3491.
40. Wills-Karp, M., and S. L. Ewart. 1997. The genetics of allergen-induced airway hyperresponsiveness in mice. Am. J. Respir. Crit. Care Med. 156:S89-S96.
41. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258-2261.
42. Wills-Karp, M., J. Santeliz, and C. L. Karp. 2001. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat. Rev. Immunol. 1:69-75.
43. Yu, C. K., S. C. Lee, J. Y. Wang, T. R. Hsiue, and H. Y. Lei. 1996. Early-type hypersensitivity-associated airway inflammation and eosinophilia induced by Dermatophagoides farinae in sensitized mice. J. Immunol. 156:1923-1930.
44. Zhang, Y., W. J. Lamm, R. K. Albert, E. Y. Chi, W. R. Henderson, Jr., and D. B. Lewis. 1997. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am. J. Respir. Crit. Care Med. 155:661-669.